PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lowance Center for Human Immunology, Division of Immunology and Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, GA.\', \'Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.\', \'Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA.\', \'Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children\'s Healthcare of Atlanta, Atlanta, GA.\', \'Center for Cystic Fibrosis and Airways Disease Research, Children\'s Healthcare of Atlanta, Atlanta, GA.\', \'Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; and.\', \'Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, GA.\', \'Lowance Center for Human Immunology, Division of Immunology and Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, GA; eliver.ghosn@emory.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.4049/immunohorizons.2200005
?:hasPublicationType
?:journal
  • ImmunoHorizons
is ?:pmid of
?:pmid
?:pmid
  • 35173021
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all